Growing outsourcing Bachem is a leading global provider of peptide and oligonucleotide development and manufacturing with a sizable international footprint and a revenue base in the hundreds of millions, indicating strong outsourcing demand and potential for expanded contract services.

End-to-end services Their offering covers research, clinical development, and commercial manufacturing, suggesting opportunities to upsell integrated services, including process development, scale-up, and GMP manufacturing for new projects.

Innovation focus As an innovation-driven firm with over five decades of expertise, there is potential to position advanced solutions such as custom synthesis, peptide libraries, and oligonucleotide optimization to address R&D pipelines of biotech and pharma customers.

Global footprint Headquartered in Switzerland with operations in Europe, the US, and Asia, Bachem’s international presence supports regional sales strategies and nearshoring or onshore manufacturing discussions for global clients.

Scale and performance The sizable workforce and substantial revenue, paired with a sizable funding backdrop, imply capacity to undertake larger engagements and multi-year programs, presenting opportunities for long-term strategic partnerships and preferred supplier status.